DTX3L inhibitors represent a class of chemical compounds that specifically target and modulate the activity of DTX3L, also known as deltex E3 ubiquitin ligase 3L. DTX3L is a protein that plays a critical role in the regulation of various cellular processes, particularly in the context of the ubiquitin-proteasome system (UPS). The UPS is a highly regulated and intricate pathway responsible for the degradation of proteins within cells. DTX3L itself is an E3 ubiquitin ligase, which means it facilitates the transfer of ubiquitin molecules onto target proteins, marking them for degradation by the proteasome. Inhibitors of DTX3L are designed to interfere with this process, ultimately influencing the stability and abundance of specific proteins within the cell.
DTX3L inhibitors typically involves binding to DTX3L and disrupting its ability to ubiquitinate target proteins. This interference can lead to the accumulation of certain proteins that are usually degraded by the UPS, thus affecting various cellular functions. While the specific targets of DTX3L inhibitors may vary, these compounds hold promise for research purposes, as they provide a means to investigate the role of DTX3L and its downstream substrates in cellular processes. Understanding the function of DTX3L and its inhibitors can shed light on fundamental cellular pathways and potentially uncover new insights into the regulation of protein turnover. Therefore, DTX3L inhibitors serve as valuable tools for studying the complex mechanisms governing protein degradation within cells, contributing to our broader understanding of cellular biology and signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Cyclin-dependent kinase 4/6 inhibitor that can reduce phosphorylation of the retinoblastoma protein, thus potentially decreasing the activity of E3 ubiquitin-protein ligase DTX3L by affecting the cell cycle. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Inhibits the interaction between p53 and MDM2, potentially increasing p53 activity which could lead to the regulation of DTX3L as part of the p53 pathway. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can increase the level of ubiquitinated proteins, potentially affecting the ubiquitin-proteasome system in which DTX3L is involved. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Analogue of thalidomide with similar action, potentially modulating the ubiquitination process and indirectly affecting DTX3L activity. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Another thalidomide analogue that can modulate the activity of E3 ubiquitin ligases, which could impact the function of DTX3L. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibitor of NEDD8-activating enzyme, potentially disrupting neddylation that affects ubiquitin E3 ligases like DTX3L. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Inhibits the enzyme thioredoxin reductase, which can lead to increased oxidative stress and potentially affect the function of DTX3L. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Increases intracellular zinc levels, which can influence multiple cellular pathways and potentially affect proteins like DTX3L. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor which can alter gene expression and potentially affect the expression or function of DTX3L. | ||||||